ID   ICANi002-A
AC   CVCL_B5EX
SY   ICAN-403.3; ICAN403.3
DR   BioSamples; SAMEA10203006
DR   hPSCreg; ICANi002-A
DR   Wikidata; Q110432901
RX   PubMed=34883448;
RX   PubMed=35093717;
RX   PubMed=38382214;
CC   From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38382214
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 17,18
ST   D21S11: 29,30
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 11,12
ST   FGA: 21,25
ST   Penta D: 9,11
ST   Penta E: 7,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 6
//
RX   PubMed=34883448; DOI=10.1016/j.scr.2021.102616;
RA   Ader F., Duboscq-Bidot L., Marteau S., Hamlin M., Richard P.,
RA   Fontaine V., Villard E.;
RT   "Generation of CRISPR-Cas9 edited human induced pluripotent stem cell
RT   line carrying FLNC exon skipping variant.";
RL   Stem Cell Res. 58:102616-102616(2022).
//
RX   PubMed=35093717; DOI=10.1016/j.scr.2022.102680;
RA   Gizon M., Duboscq-Bidot L., El-Kassar L., Bobin P., Ader F.,
RA   Giraud-Triboult K., Charron P., Villard E., Fontaine V., Neyroud N.;
RT   "Generation of a heterozygous SCN5A knockout human induced pluripotent
RT   stem cell line by CRISPR/Cas9 edition.";
RL   Stem Cell Res. 60:102680-102680(2022).
//
RX   PubMed=38382214; DOI=10.1016/j.scr.2024.103341;
RA   Bobin P., Duboscq-Bidot L., Blandin C., Perret C., Balse E.,
RA   Gandjbakhch E., Fontaine V., Villard E.;
RT   "Generation of CRISPR/Cas9 edited human induced pluripotent stem cell
RT   line carrying the heterozygous p.H695VfsX5 frameshift mutation in the
RT   exon 10 of the PKP2 gene.";
RL   Stem Cell Res. 76:103341-103341(2024).
//